These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7328963)

  • 1. [High risk group for prostatic cancer by matched pair analysis (author's transl)].
    Mishina T; Watanabe H; Araki H; Miyakoda K; Fujiwara T; Kobayashi T; Maegawa M
    Nihon Hinyokika Gakkai Zasshi; 1981 Oct; 72(10):1256-79. PubMed ID: 7328963
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiological study of prostatic cancer by matched-pair analysis.
    Mishina T; Watanabe H; Araki H; Nakao M
    Prostate; 1985; 6(4):423-36. PubMed ID: 4088954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of benign prostatic hypertrophy by matched pair analysis (author's transl)].
    Araki H
    Nihon Hinyokika Gakkai Zasshi; 1981 Nov; 72(11):1477-91. PubMed ID: 6175784
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of latent prostatic carcinoma (author's transl)].
    Yatani R
    Rinsho Byori; 1980 Aug; 28(8):785-8. PubMed ID: 7206255
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case-control study of prostatic cancer--with reference to dietary history].
    Yoshida O; Okada K; Oishi K; Ohno Y
    Gan No Rinsho; 1986 May; 32(6):591-6. PubMed ID: 3747134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of risk factors for prostatic cancer].
    Nakata S; Imai K; Yamanaka H
    Hinyokika Kiyo; 1993 Nov; 39(11):1017-24; discussion 1024-5. PubMed ID: 8266869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The detection of malignant prostatic cells in the urine. Definition of a high risk population (author's transl)].
    Benoit G; Boccon-Gibod L; Dalian G; Desligneres S
    Nouv Presse Med; 1979 Apr; 8(19):1604. PubMed ID: 492980
    [No Abstract]   [Full Text] [Related]  

  • 8. [One year prostatic carcinoma-registry (author's transl)].
    Dhom G; Kopetzky CD
    Urologe A; 1974 Mar; 13(2):96-9. PubMed ID: 4364920
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical statistics of incidence of malignant tumors in general patients and A-bomb exposed patients in Nagasaki A-Bomb Hospital during 10 years (1964-1973) (author's transl)].
    Kuwatsuka H; Takano M; Ihara K; Hakariya H; Kamimoto S
    Nihon Hinyokika Gakkai Zasshi; 1974 Aug; 65(8):527-33. PubMed ID: 4474541
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer. Epidemiology.
    Alderson MR
    Recent Results Cancer Res; 1981; 78():1-19. PubMed ID: 6168010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Topics on treatment of prostatic cancer (author's transl)].
    Nihon Hinyokika Gakkai Zasshi; 1982 Jan; 73(1):34-46. PubMed ID: 7098222
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk and preventive factors for prostate cancer in Japan: The Japan Public Health Center-based prospective (JPHC) study.
    Sawada N
    J Epidemiol; 2017 Jan; 27(1):2-7. PubMed ID: 28135193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of prostatic cancer in Japan and Asia.
    Niijima T; Koiso K
    Scand J Urol Nephrol Suppl; 1980; 55():17-21. PubMed ID: 6938022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytological diagnosis of prostatic cancer by transrectal aspiration biopsy (author's transl)].
    Clavel E; Fontanière B; Guibert B; Faucon M
    Arch Anat Cytol Pathol; 1979; 27(5):309-15. PubMed ID: 93431
    [No Abstract]   [Full Text] [Related]  

  • 15. [Symposium on the cerebral stroke. (3) Effects of long-term managements of the risk factors on primary prevention of cerebrovascular diseases (author's transl)].
    Tshushima M; Shigematsu H; Umetada Y; Hata Y; Onzuka T
    Nihon Naika Gakkai Zasshi; 1976 Dec; 65(12):1361-6. PubMed ID: 1035242
    [No Abstract]   [Full Text] [Related]  

  • 16. Soy and prostate cancer study results mixed.
    Vastag B
    J Natl Cancer Inst; 2007 Sep; 99(18):1364-5. PubMed ID: 17848664
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunochemotherapy in prostatic cancer (author's transl)].
    Morishita N; Minami Y; Ihara K
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):973-8. PubMed ID: 6275155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-androgen therapy of prostatic cancer and reactivation (author's transl)].
    Ohtsuka K
    Nihon Hinyokika Gakkai Zasshi; 1979 Nov; 70(11):1210-20. PubMed ID: 529649
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution of lymphography to the evaluation of prostatic cancer (author's transl)].
    Bergiron C; Markovits P; Allal M; Piekarski JD; Couanet D; Vanel D
    Ann Radiol (Paris); 1978; 21(6):435-9. PubMed ID: 736447
    [No Abstract]   [Full Text] [Related]  

  • 20. An epidemiological survey of prostatic cancer from the Annual of the Pathological Autopsy Cases in Japan.
    Araki H; Mishina T; Miyakoda K; Fujiwara T; Kobayashi T
    Tohoku J Exp Med; 1980 Feb; 130(2):159-64. PubMed ID: 7385225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.